Cargando…

Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium

BACKGROUND: Erythropoietin possesses cellular protection properties. The aim of the present study was to test the hypothesis that in situ expression of recombinant human erythropoietin (rhEPO) would improve tissue repair in rat after myocardial infarction (MI). METHODS AND RESULTS: RhEPO-producing c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruvinov, Emil, Sharabani-Yosef, Orna, Nagler, Arnon, Einbinder, Tom, Feinberg, Micha S, Holbova, Radka, Douvdevani, Amos, Leor, Jonathan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585557/ https://www.ncbi.nlm.nih.gov/pubmed/19014419 http://dx.doi.org/10.1186/1755-1536-1-7

Ejemplares similares

Seaweed cellulose scaffolds derived from green macroalgae for tissue engineering
por: Bar-Shai, Nurit, et al.
Publicado: (2021)

Loss of Macrophage Wnt Secretion Improves Remodeling and Function After Myocardial Infarction in Mice
por: Palevski, Dahlia, et al.
Publicado: (2017)

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)

Comparative Evaluation of Inducible Cre Mouse Models for Fibroblast Targeting in the Healthy and Infarcted Myocardium
por: Aguado-Alvaro, Laura Pilar, et al.
Publicado: (2022)

The Origin of Human Mesenchymal Stromal Cells Dictates Their Reparative Properties
por: Naftali‐Shani, Nili, et al.
Publicado: (2013)

In vitro preparation of infarcted myocardium.
por: Sasyniuk, B I
Publicado: (1978)

Massive Calcification in the Myocardium Post Infarction
por: Joshi, Prathamesh V., et al.
Publicado: (2012)

The Clinical Impact of Recombinant Human Erythropoietin
por: Muirhead, N
Publicado: (1997)

Recombinant Erythropoietin in Humans Has a Prolonged Effect on Circulating Erythropoietin Isoform Distribution
por: Aachmann-Andersen, Niels Jacob, et al.
Publicado: (2014)

Non-infarcted myocardium bears the weight in CVD
por: Zhou, Hui, et al.
Publicado: (2019)

Engineering Immunomodulatory Biomaterials for Regenerating the Infarcted Myocardium
por: Bloise, Nora, et al.
Publicado: (2020)

Pharmacokinetics of PEGylated Recombinant Human Erythropoietin in Rats
por: Cao, Xiaohan, et al.
Publicado: (2014)

Experimental myocarditis in rat can be detected and monitored by cardiac magnetic resonance imaging performed on a clinical 3.0 T scanner
por: Rinkevich-Shop, Shunit, et al.
Publicado: (2011)

Chemokine Contribution in Stem Cell Engraftment into the Infarcted Myocardium
por: Liehn, Elisa A, et al.
Publicado: (2013)

Modulators of Macrophage Polarization Influence Healing of the Infarcted Myocardium
por: ter Horst, Ellis N., et al.
Publicado: (2015)

The Role of Macrophages in the Infarcted Myocardium: Orchestrators of ECM Remodeling
por: O'Rourke, Sinead A., et al.
Publicado: (2019)

Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardium
por: Cokic, Ivan, et al.
Publicado: (2022)

Preoperative recombinant human erythropoietin in anemic surgical patients
por: Monk, Terri G
Publicado: (2004)

Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)

Acquired Pure Red Cell Aplasia and Recombinant Erythropoietin
por: Padhi, Somanath, et al.
Publicado: (2021)

Modified recombinant human erythropoietin with potentially reduced immunogenicity
por: Susantad, Thanutsorn, et al.
Publicado: (2021)

An emerging need for developing new models for myocardial infarction as a chronic complex disease: lessons learnt from animal vs. human studies on cardioprotective effects of Erythropoietin in reperfused myocardium
por: Seifirad, Soroush
Publicado: (2014)

Correlation of DTI tractography with electroanatomic mapping in normal and infarcted myocardium
por: Mekkaoui, Choukri, et al.
Publicado: (2014)

Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells
por: Gorbunov, Nikolai, et al.
Publicado: (2012)

Manganese-Enhanced T(1) Mapping in the Myocardium of Normal and Infarcted Hearts
por: Spath, N. B., et al.
Publicado: (2018)

Myocardial Infarction: The Protective Role of MiRNAs in Myocardium Pathology
por: Wang, Wei, et al.
Publicado: (2021)

Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction
por: Sharma, Vineeta, et al.
Publicado: (2021)

Engineering the Cellular Microenvironment of Post-infarct Myocardium on a Chip
por: Khalil, Natalie N., et al.
Publicado: (2021)

Identification of Hub Genes in the Remodeling of Non-Infarcted Myocardium Following Acute Myocardial Infarction
por: Wang, Lingxiao, et al.
Publicado: (2022)

Recombinant human erythropoietin for treating severe traumatic brain injury
por: Bai, Xiao-Fei, et al.
Publicado: (2018)

Modified aptamers as reagents to characterize recombinant human erythropoietin products
por: Jankowski, Wojciech, et al.
Publicado: (2020)

Cross-platform transcriptomic profiling of the response to recombinant human erythropoietin
por: Wang, Guan, et al.
Publicado: (2021)

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
por: Eisenga, Michele F., et al.
Publicado: (2020)

Renal interstitial fibroblasts coproduce erythropoietin and renin under anaemic conditions
por: Miyauchi, Kenichiro, et al.
Publicado: (2021)

Altered expression of microRNAs in the myocardium of rats with acute myocardial infarction
por: Shi, Bing, et al.
Publicado: (2010)

The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction
por: Wang, Yiming, et al.
Publicado: (2013)

The native T(1) in remote myocardium of patients with prior chronic infarction is not normal
por: Bellm, Steven, et al.
Publicado: (2016)

The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes
por: Anzai, Atsushi, et al.
Publicado: (2017)

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.
por: Barosi, G., et al.
Publicado: (1998)

Trends in Use, Cost, and Outcomes of Human Recombinant Erythropoietin, 1989-98
por: Greer, Joel W., et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_mkuprriblp45kcahr2hv58l8i6